Brain (and spinal cord) tumours
Results
Phase 1
This trial looked at different doses of enzastaurin and temozolomide for glioma brain tumours.
Recruitment start: 3 August 2007
Recruitment end: 20 November 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Roy Rampling
Eli Lilly and Company Limited
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 21 May 2012
CRUK internal database number: 2860